Topics

CytoDyn unveils updated results from HIV trial for PRO 140

06:40 EDT 15 Aug 2019 | SmartBrief

Updated data from the dose-escalation trial evaluating CytoDyn's HIV candidate PRO 140, or leronlimab, showed that patients w -More

Original Article: CytoDyn unveils updated results from HIV trial for PRO 140

NEXT ARTICLE

More From BioPortfolio on "CytoDyn unveils updated results from HIV trial for PRO 140"

Quick Search

Relevant Topic

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...